0001795091 1 2026-09-10 2026-09-10 0001795091 2 2026-09-10 2026-09-10 0001795091 2026-09-10 2026-09-10 iso4217:USD pure shares 424B7 EX-FILING FEES 0001795091 333-289443 N/A N/A S-3 OS Therapies Incorporated false Equity Common Stock, par value $0.001 per share true 5874094 1.67 9809737.00 0.0001381 1355.00 true Equity Common Stock, par value $0.001 per share true 0 0.00 0.00 0.00 9809737.00 1355.00 0.00 0.00 1355.00 Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock, par value $0.001 per share (“Common Stock”), of OS Therapies Incorporated (the “Registrant”) being registered hereunder include such indeterminate number of shares of Common Stock as may be issuable as a result of stock splits, stock dividends, or other distribution, recapitalization or similar events.<br/><br/>The offering price estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The maximum offering price per share and maximum aggregate offering price are based upon the average of the high and low sales prices of the Registrant’s Common Stock on September 2, 2026, as reported on NYSE American.<br/><br/>The amount registered represents (i) 600,000 shares of outstanding Common Stock, (ii) 900,000 shares of Common Stock issuable upon exercise of outstanding pre-funded warrants, (iii) 1,500,000 shares of Common Stock issuable upon exercise of outstanding warrants and (iv) 2,874,094 shares of Common Stock issuable upon conversion of our outstanding senior secured convertible promissory notes, each of which is to be offered for resale from time to time by certain of the selling stockholders named in the prospectus that forms a part of the registration statement to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock, par value $0.001 per share (“Common Stock”), of OS Therapies Incorporated (the “Registrant”) being registered hereunder include such indeterminate number of shares of Common Stock as may be issuable as a result of stock splits, stock dividends, or other distribution, recapitalization or similar events.<br/><br/>The offering price estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The maximum offering price per share and maximum aggregate offering price are based upon the average of the high and low sales prices of the Registrant’s Common Stock on September 2, 2026, as reported on NYSE American.<br/><br/>The amount registered represents (i) 600,000 shares of outstanding Common Stock, (ii) 900,000 shares of Common Stock issuable upon exercise of outstanding pre-funded warrants, (iii) 1,500,000 shares of Common Stock issuable upon exercise of outstanding warrants and (iv) 2,874,094 shares of Common Stock issuable upon conversion of our outstanding senior secured convertible promissory notes, each of which is to be offered for resale from time to time by certain of the selling stockholders named in the prospectus that forms a part of the registration statement to which this exhibit is attached.